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doi:10.1016/j.jtcvs.2005.09.018bjective: The histopathologic abnormality underlying ascending aortic aneurysm
nd dissection is medial degeneration, a lesion that is described as the noninflam-
atory loss of smooth muscle cells and elastic fibers. This study sought to determine
hether inflammatory cells are present in medial degeneration and assess any
ossible contribution of these cells to apoptosis of smooth muscle cells.
ethods: Aortic specimens were obtained from patients undergoing prophylactic
urgical repair of an ascending aortic aneurysm (n  9) and type A dissection (n 
), along with control patients dying of causes unrelated to aortic disease (n  5).
mmunohistochemical staining was performed to evaluate the presence of lympho-
ytes and macrophages, and markers of apoptosis were assessed in the aortas of
atients with ascending aortic aneurysm and dissection.
esults: Immunohistochemical study indicated significantly more CD3 cells in the
ortas of patients with aneurysms or dissections than in control aortas (P .020 and
 .0022, respectively). In addition, aortas of patients with aneurysms or dissec-
ions had more CD68 cells (P .01 and P .005, respectively). CD3 cells were
ocalized in the media and surrounding the vasa vasorum in the adventitia. Cells
ielding a positive result on in situ terminal transferase–mediated deoxyuridine
riphosphate nick end-labeling were found in increased numbers in the aortas of
atients with aneurysms or dissections relative to control aortas (P  .005 and P 
002, respectively). Furthermore, Fas and FasL were increased in the aortic samples
rom patients with aneurysms and dissections relative to control aortas.
onclusion: The coexistence of inflammatory cells with markers of apoptotic
ascular cell death in the media of ascending aortas with aneurysms and type A
issections raises the possibility that activated T cells and macrophages may con-
ribute to the elimination of smooth muscle cells and degradation of the matrix associ-
ted with thoracic aortic aneurysms and dissections.
he major disease processes affecting the aorta are aortic aneurysms and
dissections, and these diseases account for nearly 16,000 deaths annually.
The most common aortic aneurysms are infrarenal abdominal aortic aneu-
ysms (AAAs), followed by ascending thoracic aortic aneurysms (TAAs). TAAs
nd type A aortic dissections (TADs) are related conditions, as evidenced by the fact
hat progressive enlargement of a TAA can lead to a TAD in the absence of
rophylactic surgical repair. The pathology associated with AAAs is atherosclerosis.
n contrast, the most common pathology associated with TAAs and TADs is
rdheim cystic medial necrosis, which is described as a noninflammatory lesion
haracterized by a triad of smooth muscle cell (SMC) loss, fragmentation of elastic
bers, and accumulation of basophilic ground substance within cell depleted areas
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CSPf the medial layer of the aorta.1 Because the lesion is
either necrotic nor cystic, more recently the term medial
egeneration has been adopted to describe this pathology.
edial degeneration is not just a pathologic condition but is
ommonly seen in aging aorta and in patients with hyper-
ension.2,3 It has been shown that these changes are both
ualitatively and quantitatively much greater in patients
ith TADs.4 The lesion is also observed in genetic condi-
ions that predispose individuals toward TAA and TAD,
uch as Marfan syndrome and familial TAD.5,6
Inflammation has been documented in only a small number
f causes of human TAAs, such as giant cell arteritis, syphilitic
ortitis, and very rare cases of inflammatory aneurysms.7-9 In
his study, we tested the hypothesis that immune infiltrates are
resent in the aortas of patients with medial degeneration and
hat the presence of these inflammatory cells contributes to the
ocal expression of death-promoting mediators in the diseased
ortas. We observed that T lymphocytes and macrophages
ere present in the aortic media in both TAAs and TADs but
ccurred in greater numbers in the aortas of patients who had
issections. We observed that the aortas from patients with
neurysms and dissections had higher levels of Fas, FasL, and
aspase-3 than did normal aortas, indicating that these path-
ays are activated in both aortic diseases. With a combination
f immunostaining and in situ terminal transferase–mediated
eoxyuridine triphosphate nick-end labeling (TUNEL), we
etected numerous TUNEL-positive cells that exhibited ei-
her SMC markers or CD3 staining, evidence that both
-actin–positive and CD3 cells are undergoing apoptosis.
hus this study indicates that inflammation is a component
f medial degeneration and may contribute to apoptosis and
egeneration of the aortic wall during the development of
neurysms and dissections.
aterials and Methods
ortic Tissue
fter appropriate informed consent was obtained, full-thickness
ortic wall specimens were collected above the aortic valve
rom patients undergoing elective repair of TAA (n  9, 3 male
nd 6 female, average age 62.9 years) and emergency repair of
cute TAD (n  7, 4 male and 3 female, average age 59.9
ears). All patients had tricuspid aortic valves. None of the
atients had a known genetic syndrome causing the aortic
Abbreviations and Acronyms
AAA  abdominal aortic aneurysm
SMC  smooth muscle cell
TAA  ascending thoracic aortic aneurysm
TAD  type A aortic dissection
TUNEL terminal transferase–mediated deoxyuridine
triphosphate nick-end labelingisease (eg, Marfan or Turner syndrome) or a family history of i
72 The Journal of Thoracic and Cardiovascular Surgery ● MarcAA or TAD. Control ascending aortas were obtained from 5
ndividuals found at autopsy to have died of causes unrelated to
ortic disease (2 male and 3 female, average age 57.2 years).
edical histories pertinent to aortic disease were obtained from
he patients’ medical records (Table E1). Specimens were im-
ediately transferred to the laboratory in a container with cold
aymouth MB 752/1 medium (Invitrogen Corporation, Carls-
ad, Calif). Each sample was divided into two parts. The first
art was used for histopathologic studies, and the second was
sed for protein and RNA extraction and for explanting SMCs.
he study was approved by the institutional review committee
t the University of Texas Health Science Center at Houston
nd Memorial Hermann Hospital.
MC Culture
ortic layers were separated, minced, and digested for 16 hours in
n enzyme mixture containing elastase type III (15 U/mL), colla-
enase type I (165 U/mL), and soybean trypsin inhibitor (0.375
g/mL). Digestion was stopped with SmGm2 medium (BioWhit-
aker Molecular Applications, Rockland, Maine) supplemented
ith 20% fetal bovine serum. The released cells were washed,
elleted, and seeded into tissue culture flasks.
NA Preparation and Quantitative Reverse
ranscriptase–Polymerase Chain Reaction
otal RNA was purified from aortic tissue and SMC cultures with
RIzol Reagents (Invitrogen, Carlsbad, Calif.). First-strand com-
lementary DNA was synthesized with the Superscript II Reverse
ranscriptase Kit (Invitrogen) and CD3-specific reverse primers.
he primers were 5=-CCCCAGAGGAAGCAAACCA-3= (for-
ard) and 5=-TGGCCACCGACATCACATC-3= (reverse). Real-
ime polymerase chain reaction was performed with the Quan-
iTectTM SYBR Green PCR kit (QIAGEN Inc, Valencia, Calif)
n ABI 7700 Real-Time PCR system (Applied Biosystems,
oster City, Calif.). -Actin was used as the endogenous
tandard.
UNEL Testing
UNEL reaction was performed with an in situ cell detection kit
Promega Corporation, Madison, Wis) according to a standard pro-
ocol. Counterstaining for total nuclei was performed by mounting the
ections with 4=,6-diamidino-2=-phenylindole–containing glycerol
olution. Total and TUNEL-positive nuclei were counted in 10
ontiguous high-power fields under an Olympus fluorescent mi-
roscope (Olympus America Inc, Melville, NY) then converted to
UNEL-positive nuclei per square millimeter by two independent
bservers (R.H. and D.-C.G.).
mmunohistochemical Testing
he antibodies and supplier used are listed in Table E2, and
iotin-conjugated antibodies (Vector Laboratories, Inc, Burlin-
ame, Calif) were used as second antibody. An avidin-alkaline
hosphatase–fast red reagent or the peroxidase-DAB system (Vec-
astain ABC kit; Vector Laboratories) was used to visualize the
ntibody stains. Normal mouse immunoglobulin G (Sigma, St
ouis, Mo) served as the control for the immunostains. Infiltratednflammatory cells were counted in 10 contiguous high-power
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Pelds under an Olympus fluorescent microscope by two indepen-
ent observers.
For double staining with TUNEL and immunostaining, the
araffin sections were stained by DeadEnd Fluorometric or Col-
rimetric TUNEL system (Promega Corporation, Madison, Wis),
ollowed by immunohistochemical assay with an avidin-alkaline
hosphatase–fast red reagent or the peroxidase-DAB system. The
UNEL-positive nuclei emitted green fluorescence when the
eadEnd Fluorometric TUNEL system was used or stained brown
hen the DeadEnd Colorimetric TUNEL System was used. Im-
unostaining for cell type–specific antigens showed pink color,
hich was clearly visible under a bright field microscope.
For assessing the amount of SMC -actin staining, the IT3
mageTool (http://ddsdx.uthscsa.edu/dig/itdesc.html; Department
f Dental Diagnostic Science, The University of Texas Health
Figure 1. T-lymphocyte infiltrates in TAA and TAD. Fo
bottom. A through C, Immunohistochemical staining d
control aorta. D, F, and G, Media from patients with T
media of aorta. E, Adventitia from patient with TAA de
CD4 and CD8 cells are present in aortic media from
with TAA demonstrates that CD1 and CD68 cells ar
antibody used in D was obtained from DAKO Corporatio
E through F were obtained from Zymed Laboratories
magnification 400.cience Center, San Antonio, Tex) was used to trace areas of positive n
The Journal of Thoracic-actin staining. The pixels of the area with positive -actin stain-
ng were quantified in a 10magnification field for 5 patients with
AA, 6 with TAD, and 4 control patients.
tatistical Analysis
he CD3, TUNEL, and CD68 signals were counted in 10 contig-
ous high-power fields under an Olympus fluorescent microscope
or each individual. The averaged values of these counts for each
ndividual were used for later group comparisons. The 2-tailed
tudent t test was conducted to compare the difference in mean
alues between study and control groups.
Further, the CD3, TUNEL, and CD68 values were treated as
onparametric data and expressed as median values. Mann-Whit-
ey Wilcoxon rank-sum tests were used to compare groups on
entation, lumen of aorta is at top with adventitia at
strates that CD3 cells (arrow) are rarely present in
nd TAD demonstrate CD3 cells (arrows) throughout
trates CD3 cells throughout adventitia. H through J,
ients with TAA and TAD. K and L, Media from patient
sent in aneurysmal aortic media. Monoclonal anti-CD3
arpinteria, Calif; antibodies in panels A through C and
South San Francisco, Calif, for comparison. Originalr ori
emon
AA a
mons
pat
e pre
n, C
Inc,onparametric data from CD3, TUNEL, and CD68. All tests of
and Cardiovascular Surgery ● Volume 131, Number 3 673
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CSPignificance were 2-sided. All analyses were performed with SAS
oftware (version 8.2; SAS Institute, Inc, Cary, NC).
esults
oss of SMCs and Elastic Fibers in
edial Degeneration
he control aortas showed an orderly array of SMCs and
lastic fibers in the media (Figure E1, A). In contrast, the
ortas of the patients with TAAs and TADs showed medial
egeneration affecting primarily the SMCs, leading to
ands of cellular loss in the aortic media (Figure E1, B),
egions with primarily the elastic fibers associated with
ncreased basophilic ground substance, resulting in the ap-
earance of cystlike structures (Figure E1, C), or both.10
onsistent with the hematoxylin and eosin staining results,
mmunostaining with monoclonal antibody against SMC
-actin showed reduced numbers of SMC -actin–positive
ells in medial bands in the diseased aortas, with focal loss
f both SMCs and elastic fibers (Figure E1, D through F).
he amount of -actin staining was assessed quantitatively
ith a digital image analysis system. The amount of staining
n histologic sections of control aortas (388,701 pixels) was
-fold that in aneurysms (73, 417 pixels, P  .001) or
issected aortas (75,906 pixels, P  .001).
D3 and CD68 Cells in the Aortas from Patients
ith TAA and TAD
mmunohistochemical staining was used to determine
hether inflammatory cells, specifically T cells and macro-
hages, were present in the aortic media of patients with
AAs with medial degeneration. Two different monoclonal
nti-CD3 antibodies were used for pan–T lymphocyte de-
ection, along with a monoclonal antibody against leukocyte
ommon antigen (CD45) and a polyclonal antibody specific
or macrophages (CD68). Rare CD3 cells and macrophages
ere observed in the control aortas in the media or adventitia
Figure 1, A through C). In the aortas of patients undergoing
rophylactic repair of a TAA, there were significant in-
reases in the number of CD3 cells relative to control
ortas (P  .02; Figures 1, D through F, and 2). CD3 cells
ere observed throughout the aortic media, either scattered
hroughout or localized in foci. Some CD3 cells had the
ypical round appearance of lymphocytes, but other CD3
ells had a flattened morphology similar to SMCs (Figure 1,
, arrows). The CD3 cells were present in similar abun-
ance when a different monoclonal antibody against CD3
as used for staining. Interestingly, there was a consider-
ble influx of CD3 cells in the walls of the vasa vasorum
n the adventitia that was not present in control aortas
Figure 1, B and E). Staining of endothelial cells with an
ntibody directed against Von Willebrand factor verified
hat the CD3 cells were associated with the vasa vasorum
n the adventitia (data not shown). The presence of CD3
ells was confirmed by immunostaining with an antibody to C
74 The Journal of Thoracic and Cardiovascular Surgery ● MarcD45, an antigen present on all lymphocytes. CD45 cells
ad a similar distribution to that of the CD3 cells in the
edial layer.
Focal and diffuse accumulations of CD3 cells were
etected in aortas of patients with TADs, and the numbers
f these cells were increased relative to control aortas (P 
022) and to aneurysmal aortas (P  .019; Figures 1, G, and 2).
D3 cells were observed both along the edges of ruptured
edia of the dissected aortas and distributed throughout the
edia with a flattened morphology.
To assess the T-cell subsets within aortic lesions, the
ections were stained with antibodies that recognized CD4
nd CD8 antigens, markers for helper and cytotoxic T cells,
espectively. Both CD4 and CD8 T-cell subsets were pre-
ented in the aneurysmal and dissected aortas but not in control
ortas (Figure 1, H through J). Immunostaining with antibod-
es directed against CD1 antigen indicated that vascular
endritic cells were frequently observed in the areas con-
aining a large number of T cells but were not found in
ontrol aortas (Fig. 1K). Finally, immunostaining with
D68 antibody also indicated that macrophages were fre-
uently present in the aortas from patients with ascending
ortic aneurysm and dissection (Fig. 1L).
The flattened appearance of the CD3 cells raised the
uestion as to whether some SMCs were expressing the
D A T A A T l o r t n oC
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igure 2. CD3 cells present in media from control, aneurysmal,
nd dissected aortas. CD3 cells in 1 mm2 of aortic media were
ounted from aortic tissue sections from control subjects, pa-
ients with TAAs, and patients with TADs. Total areas examined
ere 2.2 mm2. Box-whisker plots display CD3. Central horizontal
ars indicate median, upper and lower ends of boxes indicate
5th and 25th percentiles, and error bars indicate maximum and
inimum values of CD3 values. P values were determined by
ann-Whitney Wilcoxon rank-sum tests.D3 antigen, and double staining using monoclonal anti-
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Podies against CD3 and SMC -actin was done to address
his question. The double staining revealed that the majority
f cells positive for SMC -actin were distinct from those
taining for CD3 (Fig. 1C and G). However, in certain
egions with leukocyte accumulation, an overlap of CD3
nd SMC -actin immunostaining was observed. To further
ddress this question, total RNA was isolated from control
nd aneurysmal aortas and explanted SMC cultures from
atients with TAA, and messenger RNA (mRNA) expres-
ion of the CD3 polypeptide was determined with quanti-
ative reverse transcriptase–polymrase chain reaction. Consis-
ent with the results of immunohistochemical staining, we
etected CD3 mRNA in the total mRNA isolated from
ortas of patients with TAAs but not from mRNA from the
Figure 3. Increased TUNEL-positive and FasL stainin
TUNEL-positive cells (arrows) are rarely present in con
demonstrated TUNEL-positive cells (arrows). D throu
immunohistochemical assay with -actin, CD3, and CD
macrophages were undergoing apoptosis (arrows) in ao
A through C and E used DeadEnd Colorimetric TUNEL S
TUNEL System. Bottom: A and C, Adventitia and media
of vasa vasorum and aortic media. B and D, Same vasa
which indicated colocation of CD3 and FasL-positiveontrol aortas. CD3 mRNA was not detected in the total l
The Journal of ThoracicRNA isolated from SMC cultures explanted from aneu-
ysmal aortas, providing further data that the SMCs are not
xpressing CD3.
Immunohistochemical testing with a polyclonal antibody
irected against CD68 was used to determine whether mac-
ophages were also present in the diseased aortic tissue.
umbers of macrophages were significantly increased in the
edia in both aneurysmal (5.5  1.8 cells/mm2, P  .01)
nd dissected (6.0  1.4 cells/mm2, P  .005) aortas
elative to control aortas (0.7  0.2 cells/mm2).
AAs and TADs Exhibit Increased Markers
f Apoptosis
o test the hypothesis that infiltration of T lymphocytes
media of aneurysmal and dissected aortas. Top: A,
orta. B and C, Media from patients with TAA and TAD
F, Double staining with combination of TUNEL and
tibodies demonstrated that SMCs, T lymphocytes, and
media from patient with TAA. TUNEL staining in panels
m; that in panels D and F used DeadEnd Fluorescence
eurysmal aorta indicate influx of CD3 cells in walls
rum and media were stained with anti-FasL antibody,
s. Magnification 400.g in
trol a
gh
68 an
rtic
yste
in an
vaso
celleads to activation of the death-promoting pathways through
and Cardiovascular Surgery ● Volume 131, Number 3 675
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CSPas-FasL engagement and caspase activation, DNA frag-
entation was initially analyzed on the aortic specimens
ith the TUNEL assays. Aortas from patients without aortic
isease showed few TUNEL-positive cells (Figures 3, A
op, and 4). In contrast, TUNEL-positive cells were present
n aortas from both the TAA group (P  .005) and the TAD
roup (P  .002) at significantly higher levels than in control
ortas, with significantly higher numbers of TUNEL-positive
ells in the dissected aortas (Figures 3, A top through C top,
nd 4). The TUNEL-positive cells were primarily distrib-
ted in the regions with elastic fibril loss, and there was
ocal accumulation at the edges of ruptured media in the
issected aortas (Figure 3, C top). Double immunostaining
ith a combination of TUNEL and immunohistochemical
echniques confirmed the colocation of TUNEL-positive
ells with SMCs, lymphocytes, and macrophages (Figure 3,
top through F top).
Immunohistochemical testing demonstrated diffuse staining of
mmunoreactive Fas antigens throughout the media and
dventitia of the control aorta, with increased amounts in
oth locations in the diseased aortas (data not shown). In
ontrast, staining for FasL was mainly associated with cells
n the adventitia, in particular around the vasa vasorum,
D A T A A T l o r t n o C
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igure 4. TUNEL-positive cells present in media from control,
neurysmal, and dissected aortas. TUNEL-positive cells in 1 mm2
f the aortic media were counted from aortic tissue sections from
ontrol patients, patients with TAAs, and patients with TADs.
otal areas examined were 2.2 mm2. Box-whisker plots display
UNEL. Central horizontal bars indicate median, upper and lower
nds of boxes indicate 75th and 25th percentiles, and error bars
ndicate maximum and minimum values of TUNEL values. P val-
es were determined by Mann-Whitney Wilcoxon rank-sum tests.ith occasional positive cells in the media of aneurysmal g
76 The Journal of Thoracic and Cardiovascular Surgery ● Marcnd dissected aortas colocated with the CD3 cells (Figure
, A bottom through D bottom). Consistent with the results
btained with immunohistochemical testing, increased lev-
ls of Fas and FasL antigen were detected in the aneurysmal
nd dissected tissues relative to control aortas (Figure E2).
n contrast, the control aortas displayed modest expressions
f Fas and FasL immunoreactivity. Furthermore, both the
neurysmal and dissected aortas showed immunoreactivity
o activated caspase-3, whereas control aortas showed al-
ost no activated caspase-3 (Figure E2).
iscussion
edial degeneration associated with TAAs and TADs was
riginally described by Erdheim1 as a noninflammatory
esion associated with loss of SMCs and elastic fibers in the
edia. Evidence presented in this report indicates that T
ymphocytes and macrophages are common features in the
ortas of patients with medial degeneration. Immunohisto-
hemical testing with two different monoclonal antibodies
irected against CD3 clearly showed the presence of T
ymphocytes in the media, either diffusely throughout the
edia or in focal accumulations. Some of the CD3 cells
ith flattened appearance in the aortic media resided be-
ween the SMC layers, suggesting a close interaction be-
ween these inflammatory cells and the vascular cells. Flat-
ened perforin-positive cells, presumably T lymphocytes,
ere previously observed in AAAs, indicating that lympho-
ytes may assume this morphologic appearance in the aortic
edia.11 The infiltration of CD3 cells in the walls of the
asa vasorum in this study suggests that the T cells might
igrate from these blood vessels of the adventitia into the
edia of the aortas. This study also demonstrated increased
D68 cells in the diseased aortas, indicating the presence
f macrophages in this lesion.
A number of previous studies have documented evidence
f increased apoptosis of SMCs in medial degeneration.12,13
mmunohistochemical testing has indicated that medial de-
eneration of aorta is associated with p53 accumulation,
ax upregulation, and apoptosis of SMC in the aortas of
atients with TAD.14 Our study showed an increase in the
mount of apoptotic cells by TUNEL staining in the media
f both aneurysmal and dissected aortas. Double staining for
UNEL-positive nuclei and cell-specific markers provides
vidence that SMCs are undergoing apoptosis, and to a
esser extent are lymphocytes and macrophages. Immuno-
istochemical results indicate colocation of FasL staining
ith CD3 staining, suggesting that T lymphocytes were the
ells responsible for FasL production. In contrast, Fas was
ound diffusely throughout the media and adventitia. These
esults suggest apoptosis of primarily SMCs through the
as-FasL pathway in aneurysmal tissue. The relative lack of
vidence that substantial numbers of CD3 cells are under-
oing apoptosis suggests that the aorta is not an immune-
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Privileged site in which the Fas produced by SMCs leads to
poptosis of T lymphocytes to limit an inflammatory reaction.
The T lymphocyte and macrophage infiltration and
UNEL staining were more pronounced in the media of the
issected aortas than of the aneurysmal aortas. The dissec-
ion of blood into the wall of the aorta is a traumatic tissue
njury, and it is therefore not surprising that inflammatory
arkers and apoptotic markers would be increased in the
amaged tissue. Although both inflammatory and TUNEL-
ositive cells were observed along the margin of the dis-
ections, the inflammatory cells and apoptotic markers were
lso present throughout the media. It is possible that the
egree of inflammation and apoptosis in the media may be
ncreased in an aorta before dissection. These events could
otentially lead to increased rates of loss of SMCs and
estruction of the tissue, setting the stage for the dissection
o occur. The current recommendation is to prophylactically
epair an aneurysm involving the ascending aorta to prevent
issection when it is larger than 5 cm in diameter or when
he aorta is rapidly enlarging.15 Some have dissection when
he aorta is minimally enlarged, however, and future studies
ill determine whether this premature dissection is related
o the degree of inflammation and apoptosis in the aortic
edia.
Inflammation producing enzymatic remodeling of the
ascular extracellular matrix is emerging as a shared patho-
ogic mechanism in a variety of vascular diseases, including
therosclerosis, AAAs, and intracranial aneurysms. AAAs
re characterized by atherosclerosis leading to a thinning of
he tunica media and rarefaction of SMCs.11,16 Many medial
MCs in AAAs bear markers of apoptosis and signals
apable of initiating cell death, implying that apoptotic
eath may contribute to the reduction of cellularity and
mpaired matrix homeostasis. CD4 and CD8 T cells are
lso present in AAAs, and these cells have been shown to
xpress cytotoxic mediators, including Fas and perforin,
hich causes death of T cell-targeted cells. The contribution
o elimination of SMCs of death-promoting products of
ctivated immune cells was suggested by the observations
ade in this study of TAAs and TADs associated with
edial degeneration. Thus this study provides new evidence
hat inflammatory infiltrate of T cells expressing Fas may
ontribute to TAAs in a similar fashion as to AAAs.
It is important to acknowledge the limitations of a study
hat uses surgically removed human aneurysmal aortas.
AAs were not removed until the diameter of the aorta
eached 5.0 to 5.5 cm, and TAD represents an acute trau-
atic insult to the aorta. Therefore these studies involved
nd-stage tissues for both disease processes. Furthermore,
he patients were placed on cardiopulmonary bypass and
ypothermic circulatory arrest and treated with aprotinin to
imit inflammation, and we cannot exclude the possibility
hat these procedures induced inflammatory cells in the
The Journal of Thoracicortic wall. The results presented on these tissues cannot be
xtrapolated to earlier phases of aneurysm formation. The
evelopment of homozygous mice with a hypomorphic fbn1
llele as an animal model of Marfan syndrome has shed
ome insight into the role of inflammation in the pathogen-
sis of aneurysms and dissections.17,18 Homozygous mice
ie at a few months of age, with half of the deaths resulting
rom vascular rupture. A surprising observation in these mice
s the presence of a monocytic infiltration of the medial layer,
vident from 8 weeks on that correlated with fragmentation of
lastic lamellae, loss of elastin content, and dilation of the
essel wall. Thus the only mouse model of TAA and TAD
lso demonstrates an inflammatory infiltrate in the aortic
all.
In summary, the data in this study provide the first
vidence that medial degeneration of the aorta, originally
escribed by Erdheim,1 is associated with T-lymphocyte
nd macrophage infiltration into the media of the aortic
all. Immunoblot and immunohistochemical analyses sug-
est that death-promoting signaling factors from the T lym-
hocytes may contribute to SMC apoptosis. In addition to
poptosis of the SMCs, evidence is emerging that the SMCs
ave an altered phenotype, which includes increased syn-
hesis of matrix metalloproteinases and tissue inhibitors of
etalloproteinases. An imbalance between matrix metallo-
roteinases and tissue inhibitors of metalloproteinases in the
issue may lead to elastic fiber degradation, further decreas-
ng the anchoring of the SMCs to these matrix structures. A
ore detailed pathogenesis for medial degeneration is
merging, with an altered SMC phenotype, degradation of
he elastic fibers, T-cell infiltration, and apoptosis of the
MCs playing roles in this pathologic lesion.
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PABLE E1. Clinical information of individuals participating in the study
Sample Group Age (y) Sex Hypertension Smoker Aortic diameter (cm)
2613 Control* 44 Male NA NA NA
2664 Control† 48 Female NA NA NA
2701 Control‡ 54 Female NA NA NA
2840 Control§ 74 Female NA NA NA
2976 Control2 66 Male NA NA NA
2478 Aneurysm 74 Female Yes Yes 5.6
2496 Aneurysm 77 Female Yes No 5.9
2761 Aneurysm 49 Male Yes Yes 5.0
2762 Aneurysm 65 Female Yes Yes 6.0
2945 Aneurysm 40 Female No No 5.0
2955 Aneurysm 52 Male Yes No 5.2
3386 Aneurysm 74 Female Yes No 7.0
3387 Aneurysm 64 Female Yes Yes 5.8
3393 Aneurysm 71 Male Yes Yes 5.6
2482 Dissection 71 Female Yes No 5.7
2789 Dissection 59 Male No Yes 4.5
2813 Dissection 55 Female Yes No 5.5
2992 Dissection 62 Female Yes No 8.0
2993 Dissection 57 Male Yes Yes 5.2
3038 Dissection 56 Male Yes Yes 4.3
3418 Dissection 59 Male No No 3.8
A, Information not available. *Cause of death pulmonary embolism. †Cause of death systemic lupus erythematosus. ‡Cause of death diabetes. §Cause
f death stroke. 2Cause of death congestive heart disease.
ABLE E2. Antibodies used for immunohistochemical and immunoblot analyses
ntibody Cell type Source Manufacturer Concentration
MC -acting SMC Mouse monoclonal Sigma 1:50 IHC
D3 Pan T cell Mouse monoclonal DAKO 1:25 IHC
D3 Pan T cell Mouse monoclonal Zymed 1:1 IHC
D4 Helper T cell Mouse monoclonal DAKO 1:20 IHC
D8 Cytotoxic T cell Mouse monoclonal DAKO 1:20 IHC
D1a Dendritic cell, Langerhans cell Mouse monoclonal BD PharMingen 1:100 IHC
nterleukin 4 TH2 cell Mouse monoclonal R&D Systems 1:100 IHC, 1 mg/mL IB
nterleukin 10 TH2 cell Goat R&D Systems 1:1000 IHC, 0.1 mg/mL IB
nterferon  TH1 cell Mouse monoclonal BD PharMingen 1 mg/mL IB
D45 Leukocyte Mouse monoclonal Santa Cruz* 1:100 IHC
D68 Macrophage Rabbit polyclonal Santa Cruz* 1:100 IHC
as Inflammatory cell, SMC Mouse monoclonal BD PharMingen 1:100 IHC, 1 mg/mL IBt
asL T cell, macrophage Mouse monoclonal BD PharMingen 1:100 IHC, 1 mg/mL IB
aspase-3 Various Rabbit polyclonal BD PharMingen 1:100 IHC, 0.5 mg/mL IBHC, Immunohistochemical testing; IB, immunoblot testing. *Santa Cruz Biotechnology, Inc, Santa Cruz, Calif.
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CSPFigure E1. Medial degeneration of aorta associated with loss of SMCs and elastic fibers. Representative
cross-sections of human control and aneurysmal aortic tissue were stained with hematoxylin and eosin (A-C) or
with monoclonal antibody directed against SMC -actin (D-F). A and D, Media from control aorta demonstrates
nuclei and elastic fibers throughout media. B and E, Media from patient with TAA reveals loss of cell nuclei in band
in media, but elastic fibers remain. C and F, Media in different field from same patient as in B and E displays areas
with loss of both cells and nuclei. Magnification 100.Figure E2. Immunoblot analysis showed levels of Fas, FasL, and activated caspase-3 to be increased in aneurysmal
and dissected aortas. Levels of Fas and FasL were assessed relative to actin. Increased levels of Fas antigen were
detected in aneurysmal (0.82 0.39) and dissected (0.68 0.62) tissues relative to control tissues (0.07). Increased
levels of FasL antigen were detected in aneurysmal (0.71  0.23) and dissected (0.42  0.31) tissues relative to
control tissues (0.15). Total protein loaded into each lane was 50 g. After separation by sodium dodecylsulfate–
polyacrylamide gel electrophoresis, membranes were blocked and incubated with primary antibody against Fas,
FasL, and activated caspase-3. Membranes were incubated with horseradish peroxidase–linked secondary
antibodies, followed by visualization with SuperSignal West Femto kit (Pierce Biotechnology, Inc, Rockford, Ill).
Bands correspond to following molecular weighs of proteins: Fas, 40 kd; FasL, 37 kd; activated caspase-3, 20.4 kd.
Results are consistent with results obtained with immunohistochemical testing.78.e2 The Journal of Thoracic and Cardiovascular Surgery ● March 2006
